Determining qualitative effect size ratings using a likelihood ratio scatter matrix in diagnostic test accuracy systematic reviews

Diagnosis
Matthew L RubinsteinJ Scott Parrott

Abstract

Background Diagnostic test accuracy (DTA) systematic reviews (SRs) characterize a test's potential for diagnostic quality and safety. However, interpreting DTA measures in the context of SRs is challenging. Further, some evidence grading methods (e.g. Centers for Disease Control and Prevention, Division of Laboratory Systems Laboratory Medicine Best Practices method) require determination of qualitative effect size ratings as a contributor to practice recommendations. This paper describes a recently developed effect size rating approach for assessing a DTA evidence base. Methods A likelihood ratio scatter matrix will plot positive and negative likelihood ratio pairings for DTA studies. Pairings are graphed as single point estimates with confidence intervals, positioned in one of four quadrants derived from established thresholds for test clinical validity. These quadrants support defensible judgments on "substantial", "moderate", or "minimal" effect size ratings for each plotted study. The approach is flexible in relation to a priori determinations of the relative clinical importance of false positive and false negative test results. Results and conclusions This qualitative effect size rating approach was operationalized in a r...Continue Reading

References

Jul 31, 1975·The New England Journal of Medicine·T J Fagan
Apr 1, 1991·Medical Decision Making : an International Journal of the Society for Medical Decision Making·D G Fryback, J R Thornbury
Jul 17, 1998·QJM : Monthly Journal of the Association of Physicians·A HalkinM Brezis
Dec 29, 1998·Annals of Emergency Medicine·W S Pearl
Sep 2, 1999·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J J Deeks
Mar 27, 2001·European Journal of Obstetrics, Gynecology, and Reproductive Biology·K S KhanJ Kleijnen
Mar 2, 2002·BMJ : British Medical Journal·D L Sackett, R B Haynes
Sep 6, 2002·Journal of General Internal Medicine·Steven McGee
Jan 1, 2003·Clinical Chemistry·Patrick M BossuytUNKNOWN Standards for Reporting of Diagnostic Accuracy
Jul 10, 2003·Clinica Chimica Acta; International Journal of Clinical Chemistry·Tommaso Trenti
Sep 27, 2003·BMJ : British Medical Journal·Gerd Gigerenzer, Adrian Edwards
Nov 15, 2003·Journal of Clinical Epidemiology·J A Knottnerus, J W Muris
Mar 18, 2004·Clinica Chimica Acta; International Journal of Clinical Chemistry·Andrea Rita Horvath, Daniel Pewsner
Jul 20, 2004·BMJ : British Medical Journal·Jonathan J Deeks, Douglas G Altman
Jun 18, 2005·Clinical Chemistry·Anne W S RutjesPatrick M M Bossuyt
Jul 13, 2005·Archives of Internal Medicine·Mark L GraberRuthanna Gordon
Aug 16, 2005·Lancet·Jef Van den EndeZeno Bisoffi
May 6, 2006·BMJ : British Medical Journal·Patrick M BossuytPaul Glasziou
Mar 17, 2007·Annals of Clinical Biochemistry·Robert H Christenson, UNKNOWN Committee on Evidence Based Laboratory Medicine of the International Federation for Clinical Chemistry Laboratory Medicine
Apr 26, 2008·BMJ : British Medical Journal·Gordon H GuyattUNKNOWN GRADE Working Group
May 17, 2008·BMJ : British Medical Journal·Holger J SchünemannUNKNOWN GRADE Working Group
Jun 28, 2008·Seminars in Hematology·Patrick M M Bossuyt
Dec 17, 2008·Annals of Internal Medicine·John CornellA Russell Localio
Feb 19, 2009·Journal of Pediatric Psychology·Joseph A Durlak
Mar 24, 2009·Clinica Chimica Acta; International Journal of Clinical Chemistry·Mario Plebani
Apr 23, 2009·Indian Journal of Ophthalmology·Rajul ParikhRavi Thomas
May 19, 2009·Journal of Clinical Epidemiology·Johannes B ReitsmaPatrick M Bossuyt
Jul 14, 2009·International Journal of Cardiology·Catherine M JonesThanos Athanasiou
Jan 19, 2010·Journal of Clinical Epidemiology·Andrew HayenPatrick Bossuyt
Dec 4, 2010·Annual Review of Psychology·Gerd Gigerenzer, Wolfgang Gaissmaier
Mar 29, 2011·European Journal of Epidemiology·Alex J Mitchell
Aug 10, 2011·Journal of Experimental Psychology. General·Catherine O FritzJennifer J Richler
Oct 19, 2011·Annals of Internal Medicine·Penny F WhitingUNKNOWN QUADAS-2 Group
Dec 2, 2011·BMJ Quality & Safety·Gordon D Schiff
Jan 11, 2012·International Journal of Technology Assessment in Health Care·Lukas P StaubR John Simes
Feb 16, 2012·BMC Medical Research Methodology·Lukas P StaubLes Irwig
Feb 23, 2012·BMJ : British Medical Journal·Lavinia Ferrante di RuffanoJonathan J Deeks
May 1, 2012·BMJ Quality & Safety·Mark L GraberHardeep Singh
Jun 8, 2012·Journal of General Internal Medicine·Thomas A Trikalinos, Cynthia M Balion

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen
J MeerpohlH J Schünemann
Nihon rinsho. Japanese journal of clinical medicine
Jun Okada
The Lancet Infectious Diseases
S D Goldenberg
Journal of Clinical Epidemiology
Howard BalshemG H Guyatt
© 2022 Meta ULC. All rights reserved